Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 206,152 | 64,370 | 65,348 | 43,565 | 4,960 |
| Marketable Securities | 161,985 | 216,862 | 185,109 | 71,826 | 112,904 |
| Receivables | 5,559 | 7,483 | 5,102 | 9,079 | 6,298 |
| TOTAL | $378,182 | $292,298 | $258,490 | $127,459 | $128,568 |
| Non-Current Assets | |||||
| PPE Net | 12,935 | 11,945 | 11,265 | 9,527 | 9,633 |
| Investments And Advances | 0 | 0 | 5,647 | 14,191 | 15,609 |
| Other Non-Current Assets | 2,994 | 2,994 | 2,136 | 2,698 | 2,560 |
| TOTAL | $15,929 | $14,939 | $19,048 | $26,416 | $27,802 |
| Total Assets | $394,111 | $307,237 | $277,538 | $153,875 | $156,370 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 1,000 |
| Accounts payable and accrued liabilities | 5,544 | 4,879 | 4,901 | 5,839 | 5,584 |
| Accrued Expenses | 8,823 | 5,890 | 4,520 | 2,944 | 6,017 |
| Other current liabilities | 627 | 3,438 | 2,536 | 352 | 901 |
| TOTAL | $29,597 | $29,910 | $35,460 | $32,008 | $32,967 |
| Non-Current Liabilities | |||||
| Long Term Debt | 24,545 | 24,411 | 24,281 | 24,155 | 8,876 |
| Deferred Revenues | 14,603 | 15,703 | 23,503 | 22,873 | 19,465 |
| aiOther Non-Current Liabilities | 481 | 151 | 148 | 141 | 134 |
| TOTAL | $32,466 | $33,208 | $35,321 | $39,782 | $25,614 |
| Total Liabilities | $62,063 | $63,118 | $70,781 | $71,790 | $58,581 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,892 | 38,604 | 35,879 | 23,228 | 23,099 |
| Common Shares | 46 | 38 | 36 | 23 | 23 |
| Retained earnings | -227,873 | -168,329 | -185,468 | -215,340 | -195,745 |
| Other shareholders' equity | 129 | 237 | 398 | 28 | 165 |
| TOTAL | $332,048 | $244,119 | $206,757 | $82,085 | $97,789 |
| Total Liabilities And Equity | $394,111 | $307,237 | $277,538 | $153,875 | $156,370 |